Page 226 - Cote clinical veterinary advisor dogs and cats 4th
P. 226

Atrial Premature Complexes and Atrial Tachycardia   97


             which  may be reversible  with  appropriate   Vagal maneuver:          ○   Intravenous (IV) treatment if extremely
             treatment.                        •  May suddenly terminate atrial and junctional   rapid  rate and/or  causing  clinical signs
  VetBooks.ir   DIAGNOSIS                      •  Should  have  no  effect  on  ventricular   ○   Oral  medications  to  reduce  long-term   Diseases and   Disorders
                                                                                      (e.g., severe anxiety, syncope)
                                                tachycardias or slow rate to aid in diagnosis
                                                                                      effect of uncontrolled tachycardia on
                                                tachycardia
           Diagnostic Overview
                                               may be used in diagnosing underlying cardiac
           Initial suspicion is usually based on auscultation   Thoracic radiography and echocardiography:   myocardial function
           of premature beats or a rapid heart rate. Defini-  disease or concurrent CHF.  Acute General Treatment
           tive diagnosis is made based on the electrocar-                        •  AT/SVT  producing  sustained  ventricular
           diogram (ECG).                      Advanced or Confirmatory Testing     rates > 250 beats/min in dogs often severely
                                               Electrophysiologic studies: may be used for   compromises diastolic ventricular filling and
           Differential Diagnosis              determining the underlying mechanism of   can be considered critical; IV antiarrhythmics
           •  AT  must  be  differentiated  from  sinus   arrhythmia. Not widely available.  to decrease ventricular rate are warranted.
             tachycardia; sinus tachycardia is usually an                           Patients should have an IV catheter and
             appropriate physiologic tachycardia in    TREATMENT                    continuous ECG monitoring during drug
             response to pain or anxiety.                                           administration.
           •  Uncommonly, atrial arrhythmias may coexist   Treatment Overview     •  Perform  vagal  maneuver  first.  Some  ATs/
             with aberrant conduction/bundle branch   •  Always correct underlying cause or contribut-  SVTs terminate with ocular pressure or
             block, producing wide QRS complexes and   ing factors first (e.g., CHF/hypoxemia,   carotid sinus massage. If not, judicious IV
             causing APCs and AT to appear similar to   hypokalemia, acidosis, hypovolemia).  drugs are warranted.
             VPCs and ventricular tachycardia, respectively.   •  Return hemodynamic stability, especially with   •  Calcium channel blockers: commonly used
             With APCs and AT/SVT, a P′ wave precedes   continuous  rapid  AT;  isolated,  infrequent   as first-choice agents:
             each QRS complex at a repeatable interval   APCs do not cause hemodynamic instability,   ○   Diltiazem: 0.05 mg/kg IV over 1-2 min,
             (sometimes buried in preceding T wave).  and no specific treatment is required.  repeat prn to total dose of 0.75 mg/kg,
                                               •  Conversion  of  the  arrhythmia  to  sinus   or
           Initial Database                     rhythm is not always possible, especially with   ○   Verapamil:  0.05 mg/kg  IV  q  5-10 min
           ECG (APCs):                          atrial enlargement (substrate for arrhythmia   up to total dose of 0.15 mg/kg, or 2-10
           •  A  P′ wave represents premature atrial   recurrence/persistence).       micrograms/kg/min constant rate infusion
             depolarization. Its ectopic origin (outside the   •  Control the ventricular response rate if too   •  Beta-blockers:
             sinoatrial node) means it propagates differ-  rapid.                   ○   Esmolol: 0.05-0.5 mg/kg slow IV; can
             ently through the atria than a sinus-origin   ○   Target rate is achieved with drugs that   follow with 0.05-0.1 mg/kg/min constant
             impulse, and P′ waves are therefore of dif-  slow AV node conduction to optimize the   rate infusion if needed, or
             ferent shape and occur sooner (prematurely)   ventricular rate.        ○   Propranolol: 0.02 mg/kg IV slowly over
             compared to the expected normal P waves.  ○   Target rate varies with the underlying   2-3 minutes, titrate dose up to effect (to
           •  The complete heartbeat (P′-QRS-T) occurs   cardiac disease.             maximum of 0.1 mg/kg)
             earlier than the next expected sinus beat.
           •  P′ waves may not be visible if the rate is so
             fast that they are buried in the preceding T   Z
             wave or they are isoelectric in that lead                           *                   *
             (examine other ECG leads).
           •  QRS  complexes  typically  are  narrow  and
             positive in lead II, like the patient’s sinus
             QRS complexes.
           •  APCs are usually followed by a noncompen-
             satory pause; the ectopic atrial impulse resets
             the sinus node, such that the R-R interval of
             two normal sinus complexes enclosing the
             APC is less than the R-R intervals of three   A
             consecutive sinus complexes.
           ECG (AT):
           •  Three or more APCs in a row; regular or
             slightly irregular rhythm             I I
           •  P′ waves are present but may be hidden or
             superimposed on preceding T waves.
           •  The onset and termination at AT is usually
             sudden (paroxysmal) and does not speed up
             or slow down.
           •  The P′R interval is usually constant.
           •  Narrow QRS complexes (rarely, can be wide
             with coexisting bundle branch block or
             aberrant conduction)
           •  At extremely rapid atrial rates, there may be   B
             varying degrees of AV block (i.e., noncon-
             ducted P′ waves due to refractoriness of the   ATRIAL PREMATURE COMPLEXES  A, Lead II ECG showing atrial premature complexes (asterisks) in a
                                               dog with respiratory sinus arrhythmia. A P′ wave initiates a heartbeat that is premature but with a QRS complex
             AV node).                         that is of the same shape as the sinus QRS complexes (25 mm/sec). B, Atrial/supraventricular tachycardia lead
           ECG (AV junctional tachycardia):    II ECG showing a rapid, narrow-complex, monomorphic (QRS complexes all of the same shape) tachycardia.
           •  Negative P′ waves in lead II     The heart rate is 330 beats/min. A supraventricular tachycardia is diagnosed on the basis of the narrow, upright
           •  Difficult to distinguish from AT  QRS complexes in this lead II tracing (25 mm/sec).

                                                      www.ExpertConsult.com
   221   222   223   224   225   226   227   228   229   230   231